Credit Suisse Upgrades Edwards Lifesciences (EW) to Outperform
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $86.90 -1.93%
Rating Summary:
23 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
23 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Credit Suisse upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Outperform, price target cut $2 to $88.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $73.93 yesterday.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $73.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform
- Inter Parfums (IPAR) PT Lowered to $172 at Piper Sandler
- First BanCorp (FBP) PT Raised to $21 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
